Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
HOME > REGULATORY
REGULATORY
- Ministers of Health, Finance, and Internal Affairs Agree to Add 3 Vaccines to Public Vaccination Programs in April
January 29, 2013
- PAFSC First Committee on New Drugs to Discuss Approval of Japan’s First FD Treatment
January 28, 2013
- Preliminary Meetings of Regulatory Consultations Reach 331, Increase Found in Central and Peripheral Nervous System Drugs
January 25, 2013
- New Government Economic Panel Holds First Meeting, Takeda President Hasegawa Proposes to Bring Competition to Medical Industry
January 25, 2013
- Premium for New Drug Development to Be Discussed Alongside Long-Listed Drugs, Development of Drugs Used Off-Label: Health Minister Tamura
January 25, 2013
- Draft Basic Policy for FY2013 Budget Calls for “Prioritization” in Social Security to Minimize Increase in Public Burden
January 24, 2013
- MHLW Proposes Adding Test for Alcohol Consumption and Dependence to Health Checkup Program
January 24, 2013
- MOF’s Fiscal System Council Continues to Back Reference Price System, Price Cuts for Long-Listed Drugs
January 23, 2013
- LDP Group to Make New Rules on Online OTC Drug Sales in the Diet Session, Consider Lawmaker-Sponsored Bill
January 22, 2013
- PAFSC’s 2nd Committee to Discuss GSK’s CLL Treatment Arzerra on January 31
January 21, 2013
- MHLW Mulling Measure to Encourage Welfare Recipients to Use Generics
January 21, 2013
- How Will Party’s Return Affect Healthcare and Drug Policy? LDP Back in Power for First Time in 3 Years
January 17, 2013
- MHLW to Launch Panel by Jan.-End to Discuss New Rule for Online OTC Drug Sales after Top Court Ruling
January 16, 2013
- MHLW to Make HPV, Hib, and Pneumococcal Vaccines Mandatory, Excluding Them from the FY2012 Extra Budget
January 16, 2013
- At Request of JMA, Pharmacists to Be Required to Confirm that Buyers of Switch OTC Version of Epadel Had Medical Exam Before Purchase
January 15, 2013
- Supreme Court OKs Online Sales of OTC Drugs, Rejects Govt Appeal
January 15, 2013
- MHLW Calls for Preventive Measures against Accidental Ingestion of Pharmaceutical Products by Children
January 15, 2013
- Focus May Be on Whether New Price Cutting Rule for Long-Listed Drugs Should Apply Only to Those Granted Premium
January 15, 2013
- MHLW Revises GCP Ordinance, Pushes Clinical Trials with Simple Contract Procedures
January 11, 2013
- PMDA Probes How Insurance Pharmacies Utilize Drug Safety Information
January 11, 2013
ページ
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…